SU856376A3 - Method of producing triphenylalkene derivatives - Google Patents
Method of producing triphenylalkene derivatives Download PDFInfo
- Publication number
- SU856376A3 SU856376A3 SU772446005A SU2446005A SU856376A3 SU 856376 A3 SU856376 A3 SU 856376A3 SU 772446005 A SU772446005 A SU 772446005A SU 2446005 A SU2446005 A SU 2446005A SU 856376 A3 SU856376 A3 SU 856376A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- isomer
- diphenyl
- ethanol
- general formula
- triphenylalkene
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 230000018044 dehydration Effects 0.000 claims description 4
- 238000006297 dehydration reaction Methods 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 abstract 1
- ARSRBNBHOADGJU-UHFFFAOYSA-N 7,12-dimethyltetraphene Chemical compound C1=CC2=CC=CC=C2C2=C1C(C)=C(C=CC=C1)C1=C2C ARSRBNBHOADGJU-UHFFFAOYSA-N 0.000 abstract 1
- VFZRZRDOXPRTSC-UHFFFAOYSA-N DMBA Natural products COC1=CC(OC)=CC(C=O)=C1 VFZRZRDOXPRTSC-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000006356 dehydrogenation reaction Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N 1-butanol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- -1 for example Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- KDKKRJMQCQNZDY-UHFFFAOYSA-N 1-(1,2-diphenylbut-1-enyl)-4-fluorobenzene Chemical compound C=1C=CC=CC=1C(CC)=C(C=1C=CC(F)=CC=1)C1=CC=CC=C1 KDKKRJMQCQNZDY-UHFFFAOYSA-N 0.000 description 2
- XWIKPNQTSLCDMC-UHFFFAOYSA-N 1-(4-bromophenyl)-1,2-diphenylbutan-1-ol Chemical compound C1(=CC=CC=C1)C(C(CC)C1=CC=CC=C1)(O)C1=CC=C(C=C1)Br XWIKPNQTSLCDMC-UHFFFAOYSA-N 0.000 description 2
- PKWCGWGPYGPHOQ-UHFFFAOYSA-N 1-(4-fluorophenyl)-1,2-diphenylbutan-1-ol Chemical compound C1(=CC=CC=C1)C(C(CC)C1=CC=CC=C1)(O)C1=CC=C(C=C1)F PKWCGWGPYGPHOQ-UHFFFAOYSA-N 0.000 description 2
- NUNRCACEJFCJLA-UHFFFAOYSA-N 1-bromo-4-(1,2-diphenylbut-1-enyl)benzene Chemical compound C=1C=CC=CC=1C(CC)=C(C=1C=CC(Br)=CC=1)C1=CC=CC=C1 NUNRCACEJFCJLA-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- LSZQQLHQPDOPJW-UHFFFAOYSA-N 1-(4-chlorophenyl)-1,2-diphenylbutan-1-ol Chemical compound C1(=CC=CC=C1)C(C(CC)C1=CC=CC=C1)(O)C1=CC=C(C=C1)Cl LSZQQLHQPDOPJW-UHFFFAOYSA-N 0.000 description 1
- FPGCYTJCZNIGCD-UHFFFAOYSA-N 1-but-1-enyl-4-fluorobenzene Chemical compound CCC=CC1=CC=C(F)C=C1 FPGCYTJCZNIGCD-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/35—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/24—Halogenated aromatic hydrocarbons with unsaturated side chains
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
(54) СПОСОБ ПОЛУЧЕНИЯ ТРИФЕНИЛАЛКЕНОВЫХ ПРОИЗВОДНЫХ(54) METHOD FOR PRODUCING TRIPHENYLALKENE DERIVATIVES
1one
Изобретение относитс к способу получени новых трифенилалкеновых производных общей формулыThis invention relates to a process for the preparation of new triphenylalkene derivatives of general formula
фенилалкеновых производных формулы 1 трифенилалканольное производное общей формулыphenylalkenes derivatives of the formula 1 triphenylalkanol derivative of the general formula
где R и X имеют указанные значени ) R - оксигруппа where R and X have the indicated meanings) R is a hydroxy group
RQ. - водород ,RQ. - hydrogen,
дегидратируют при кипении реакционной смеси с последующим выделением целевых продуктов в свободном виде или в виде их геометрических изомеров.dehydration at boiling of the reaction mixture, followed by separation of the target products in free form or in the form of their geometric isomers.
Предпочтите.пьно дегидратацию ведут в присутствии кислоты - сол ной, бромистоводородной, трифторуксусной или муравьиной. Геометрические изомеры обычно раздел ют фракционированной кристаллизацией или хроматографированием .Preferred. Dehydration is preferably carried out in the presence of hydrochloric, hydrobromic, trifluoroacetic or formic acid. Geometric isomers are usually separated by fractional crystallization or chromatography.
Соединени по изобретению можно примен ть дл получени фармацевтических препаратов путем превращени , по крайней мере, одного соединени общей формулы 1 в фармацевтический препарат вместе с нетоксичным фармакологически допустимым разбавлением и/или носителем.The compounds of the invention can be used to prepare pharmaceutical preparations by converting at least one compound of general formula 1 to a pharmaceutical preparation together with non-toxic pharmacologically acceptable dilution and / or carrier.
Пример 1, Раствор 135,0 г (0,355 моль) 1,2-дифенил-1-(п-бромфенил )-1-бутанола в 1400 мл этанола кип т т в течение 5 ч с 300 мл 36%ной сол ной кислоты. Этанол отгон ют в вакууме и водный остаток экстрагируют несколькими порци ми (1500 мл) метилендихлорида. Органическую фазу промывают водой до нейтральной реакции и сушат. После отгонки растворител сырой кристаллический продукт перекристаллизовывают из этанола и получают 120 г (93%) 1,2-дифенил-1- (п -бромфенил) -1-бутена с т.пл. 64-82С; отношение Z-изомера к Е-изомеру составл ет 1:1.После перекристаллизации продукта три раза из изопропанола получают Z-изомер с т.пл.112-115°С. Маточную жидкость выпаривают досуха и остаток дважды перекристаллизовывают из метанола, получают Е изомер с т.пл.89-92°С.Example 1 A solution of 135.0 g (0.355 mol) of 1,2-diphenyl-1- (p-bromophenyl) -1-butanol in 1400 ml of ethanol is boiled for 5 hours with 300 ml of 36% hydrochloric acid. The ethanol is distilled off in vacuo and the aqueous residue is extracted with several portions (1500 ml) of methylene dichloride. The organic phase is washed with water until neutral and dried. After distilling off the solvent, the crude crystalline product is recrystallized from ethanol to obtain 120 g (93%) of 1,2-diphenyl-1- (p-bromophenyl) -1-butene with m.p. 64-82С; the ratio of the Z-isomer to the E-isomer is 1: 1. After recrystallization of the product three times from isopropanol, the Z-isomer is obtained with a mp of 112-115 ° C. The mother liquor is evaporated to dryness and the residue is recrystallized from methanol twice, to obtain the E isomer with mp 89-92 ° C.
Пример 2. К раствору 320,0 (1,0 моль) 1,2-дифенил 1-(п-фторфенил )-1-бутанола в 3800 мл этанола, добавл ют 850 мл 36%-ной сол ной кислоты и смесь кип т т 1 ч. Кристаллический осадок, выпавший из охлажденного раствора, отфильтровывают и промывают несколькими порци ми воды до нейтральной реакции. После выпаривани маточной жидкости до половины исходного объема получают дополнительное количество продукта. После перекристаллизации сырого продукта (2-90 г) из 90%-ного этанола получают изомерную смесь 1,2-дифеннл-1-(п-фторфенил )-1-бутена с выходом 257,0 г-(84,9%) с т.пл.65-70°С, отношение z-изомера к Е-изомеру 1:1. Смесь изомеров раздел ют на колонке с силикагелем с размером частиц .0,063-0,2 мм, пропитанными нитратом серебра, элюирование ведут непол рным растворителем, например, петролейным эфиром или циклогексаном. Из 5 г получают 2,46 г (49,3%) 2-изомера с Т.ПЛ.77-800С и 1,21 г (24,2%) El-изомера с т.пл. 78-81ОС.Example 2. To a solution of 320.0 (1.0 mol) of 1,2-diphenyl 1- (p-fluorophenyl) -1-butanol in 3800 ml of ethanol, 850 ml of 36% hydrochloric acid are added and the mixture is boiled 1 h. The crystalline precipitate that has precipitated from the cooled solution is filtered and washed with several portions of water until neutral. After evaporation of the mother liquor to half the original volume, an additional amount of product is obtained. After recrystallization of the crude product (2-90 g) from 90% ethanol, an isomeric mixture of 1,2-diphenyl-1- (p-fluorophenyl) -1-butene is obtained in a yield of 257.0 g (84.9%) mp 65-70 ° C, the ratio of z-isomer to E-isomer 1: 1. The mixture of isomers is separated on a silica gel column with a particle size of .0.063-0.2 mm, impregnated with silver nitrate, elution is carried out with a non-polar solvent, for example, petroleum ether or cyclohexane. From 5 g, 2.46 g (49.3%) of the 2-isomer with mp T.L.77-800С and 1.21 g (24.2%) of the el-isomer are obtained with mp. 78-81ОС.
Пример 3. 30,6 г (О,10 моль 1,2-дифенил-1- (п-фторфенил) -1-пропанола раствор ют в 360 мл этанола и в течение 1 ч кип т т с 85 мл 36%-ной сол ной кислоты. Спирт выпаривают в вакууме, остаток развод т 200 мл воды и экстрагируют мл хлороформа . Органическую фазу вначале промывают 100 мл 10%-ного распора бикарэбоната натри , затем водой и высушивают над сульфатом магни . Растворитель испар етс и остаток перекристаллизовывают из этанола. Получают 25,80 г (89,5%) 1,2-дифенил-1-(п-фторфенил ) - 1-пропена, т.пл. 7 6-89 СExample 3. 30.6 g (O, 10 mol of 1,2-diphenyl-1- (p-fluorophenyl) -1-propanol are dissolved in 360 ml of ethanol and boiled for 85 hours with 85 ml of 36% hydrochloric acid. The alcohol is evaporated under vacuum, the residue is diluted with 200 ml of water and extracted with ml of chloroform. The organic phase is first washed with 100 ml of 10% sodium bicarbonate solution, then with water and dried over magnesium sulfate. The solvent is evaporated and the residue is recrystallized from ethanol 25.80 g (89.5%) of 1,2-diphenyl-1- (p-fluorophenyl) -1-propene are obtained, mp 7 6-89 C
Пример 4. 30,0 г (86 моль) 1, 2-дифенил-1- (п -фторФенш 1-гексанола раствор ют в 300 мл этанола иExample 4. 30.0 g (86 mol) of 1, 2-diphenyl-1- (n-fluoro-Fenche 1-hexanol is dissolved in 300 ml of ethanol and
в течение 1 ч кип т т с 73 мл 36%-ной сол ной кислоты. Спирт испар ют в вакууме, остаток разбавл ют 200 мл воды и экстрагируют 3x150 мл хлороформа . Органическую фазу промывают 10%-ным раствором гидрокарбоната натри , затем водой и высушивают.После испарени растворител остаток перекристаллизовывают из этанола. Получают 24,2 г (85%) 1,2-дифенил-1- (П-фторфенил)-1-гексана, т.пл.82ЭО С .for 1 h, boil with 73 ml of 36% hydrochloric acid. The alcohol is evaporated in vacuo, the residue is diluted with 200 ml of water and extracted with 3x150 ml of chloroform. The organic phase is washed with 10% sodium hydrogen carbonate solution, then with water and dried. After evaporation of the solvent, the residue is recrystallized from ethanol. 24.2 g (85%) of 1,2-diphenyl-1- (P-fluorophenyl) -1-hexane are obtained, m.p.882 EO C.
Пример 5. 5,О г (13 моль) 1,2-дифенил-1-(п -бромфенил)-1-бутанола раствор ют в 60 мл метанола и втечение 1 ч кип т т с 7,05 мл 5 (130 ммоль) 98%-ной серной кислоты. Метанол испар етс в вакууме, остаток раствор ют в 20 мл воды и экстрагируют 3x20 мл хлороформа. Объединенную органическую фазу вначале 0 промывают 20 мл 10%-ного раствора гидрокарбоната натри , затем водой, 2К20 мл и высушивают сульфатом магни . Растворитель испар етс и остаток перекристаллизовывают из этанола. 5 Получают 4,30 г (90,5%) 1,2-дифенил-1- (п-бромфенил) -1-бутена, т .пл .65-82 С . Соотношение Z-изомера к Е-изомеру составл ет 1:1.Example 5. 5, O g (13 mol) 1,2-diphenyl-1- (p-bromophenyl) -1-butanol is dissolved in 60 ml of methanol and boiled for 7 hours with 7.05 ml of 5 (130 mmol ) 98% sulfuric acid. The methanol is evaporated in vacuo, the residue is dissolved in 20 ml of water and extracted with 3x20 ml of chloroform. The combined organic phase is first washed with 20 ml of a 10% sodium hydrogen carbonate solution, then with water, 2Q20 ml and dried with magnesium sulfate. The solvent is evaporated and the residue is recrystallized from ethanol. 5 4.30 g (90.5%) of 1,2-diphenyl-1- (p-bromophenyl) -1-butene, mp 65-82 ° C is obtained. The ratio of Z-isomer to E-isomer is 1: 1.
П р и м е р 6.10,0г (31,2 ммоль) 1,2-дифенил-1- (П -фторфенил)-1-бутанола раствор ют в смеси из 100 мл трифторуксусной кислоты и 100 мл этанола и раствор кип т т в течение получаса . Реакционную смесь обрабатывают согласно примеру 5. Получают 8,40 г 5 (89%) 1,,2-д,ифенил 1-(п-фторфенил)-1-бутена , т.пл. 65-70°С. Соотношение Z-изомера к Е-изомеру составл ет 1:1. Пример 7. 5,0 г (14,8 ммоль) 1,2-дифенил-1- (п -хлорфенил)-1-бутано0 ла раствор ют в смеси из 100 мл 98%- ной муравьиной кислоты и 150 мл метанола и кип т т в течение 1 ч. После обработки реакционной смеси согласно примеру 5 получают 4,15 г (88%) 1,25 -дифенил-1-(п-хлорфенил)-1-бутена, т.пл.6В-79°С. Соотношение Z-изомера к Е-изомеру составл ет 1:1.EXAMPLE 6.10.0 g (31.2 mmol) of 1,2-diphenyl-1- (P-fluorophenyl) -1-butanol is dissolved in a mixture of 100 ml of trifluoroacetic acid and 100 ml of ethanol and the solution is boiled. within half an hour. The reaction mixture was worked up according to Example 5. 8.40 g of 5 (89%) of 1, 2-d, andphenyl 1- (p-fluorophenyl) -1-butene were obtained, m.p. 65-70 ° C. The ratio of Z-isomer to E-isomer is 1: 1. Example 7. 5.0 g (14.8 mmol) of 1,2-diphenyl-1- (p-chlorophenyl) -1-butanol is dissolved in a mixture of 100 ml of 98% formic acid and 150 ml of methanol and boils t for 1 h. After treatment of the reaction mixture according to example 5, 4.15 g (88%) of 1.25-diphenyl-1- (p-chlorophenyl) -1-butene is obtained, mp 6B-79 ° C . The ratio of Z-isomer to E-isomer is 1: 1.
Пример 8. 3,20 г (10 ммоль) 1, 2-дифенил-1- (п-фторфенил )-1-бутано0 ла в течение получаса кип т т в 38 мл этанола с 17,3 г 57,6%-ной перхлорной кислоты. Выпавшие из охлажденного раствора кристаллы отфильтровывают и промывают водой.Получают 2,44 г (81%) 1,2-дифенил-1-(п-фторфенил)-1-бутёна , т.пл.67-71°С. СоотношениеExample 8. 3.20 g (10 mmol) of 1, 2-diphenyl-1- (p-fluorophenyl) -1-butanol is boiled for 38 minutes in 38 ml of ethanol with 17.3 g of 57.6% perchloric acid. The crystals precipitated from the cooled solution are filtered and washed with water. 2.44 g (81%) of 1,2-diphenyl-1- (p-fluorophenyl) -1-butene are obtained, mp 67-71 ° C. Ratio
Z-изомера к Е-изомеру составл ет 1:1.Z-isomer to E-isomer is 1: 1.
Пример 9. 3,81 г (10 ммоль) 1,2-дифенил-1- (fi -бромфенил) -1-6утанола кип т т в течение 5 ч в 46 млExample 9. 3.81 g (10 mmol) of 1,2-diphenyl-1- (fi-bromophenyl) -1-6 butanol is boiled for 5 hours in 46 ml
0 этанола с 11,1 г 48%-ной бромистоводородной кислоты. Спирт испар етс в вакууме, остаток разводитс 20 мл воды и экстрагируетс 3x20 мл хлороформа . Объединенные органические0 ethanol with 11.1 g of 48% hydrobromic acid. The alcohol is evaporated in vacuo, the residue is diluted with 20 ml of water and extracted with 3x20 ml of chloroform. United Organic
5 фазы промывают 20 мл 10%-ного раствора бикарбоната натри , затем водой и высушивают над сульфатом магни . После испарени хлороформа остаток перекристаллизовывёиот из этанола.Получают 3,0 г (82,5%)1,2-дифенил-1- (п -брсшфенил) -1-бутена, т. пл. 65-81 С. Соотношение Z-изомера к Е-изомеру составл ет 1:1.The 5 phases are washed with 20 ml of a 10% sodium bicarbonate solution, then with water and dried over magnesium sulfate. After evaporation of chloroform, the residue is recrystallized from ethanol. 3.0 g (82.5%) of 1,2-diphenyl-1- (p-brssphenyl) -1-butene is obtained, mp. 65-81 ° C. The ratio of Z-isomer to E-isomer is 1: 1.
ю щ и с тем, что, трифенилалканольное производное общей формулыy y and with the fact that, triphenylalkanol derivative of the general formula
. .
Claims (2)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU76GO00001328A HU171269B (en) | 1976-02-05 | 1976-02-05 | Process for preparing new triphenyl-alkene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU856376A3 true SU856376A3 (en) | 1981-08-15 |
Family
ID=10996802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU772446005A SU856376A3 (en) | 1976-02-05 | 1977-01-28 | Method of producing triphenylalkene derivatives |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS52122352A (en) |
| AT (1) | AT345804B (en) |
| CA (1) | CA1087212A (en) |
| CH (1) | CH624655A5 (en) |
| DE (1) | DE2704690C2 (en) |
| HU (1) | HU171269B (en) |
| NL (1) | NL7701025A (en) |
| PL (1) | PL105534B1 (en) |
| SE (1) | SE431324B (en) |
| SU (1) | SU856376A3 (en) |
| YU (1) | YU39669B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2964736D1 (en) * | 1978-11-07 | 1983-03-17 | Ici Plc | 1-acyloxyphenyl-1,2-diphenylalkene derivatives, processes for their manufacture and a pharmaceutical composition containing these derivatives |
| US5030764A (en) * | 1986-05-23 | 1991-07-09 | Hoffmann-La Roche Inc. | Novel tetrahydronaphthalene and indane derivatives |
| ZW7487A1 (en) * | 1986-05-23 | 1987-12-16 | Hoffmann La Roche | Tetrahydronaphthaline and indane derivatives |
| US5030765A (en) * | 1986-05-23 | 1991-07-09 | Hoffmann-La Roche Inc. | Novel tetrahydronaphthalene and indane derivatives |
| AT388728B (en) * | 1987-03-17 | 1989-08-25 | Hoffmann La Roche | NEW TETRAHYDRONAPHTHALINE AND INDANDERIVATIVES |
| GB9714310D0 (en) * | 1997-07-07 | 1997-09-10 | Smithkline Beecham Plc | Process |
-
1976
- 1976-02-05 HU HU76GO00001328A patent/HU171269B/en unknown
-
1977
- 1977-01-28 SU SU772446005A patent/SU856376A3/en active
- 1977-02-01 AT AT59577A patent/AT345804B/en not_active IP Right Cessation
- 1977-02-01 NL NL7701025A patent/NL7701025A/en not_active Application Discontinuation
- 1977-02-03 SE SE7701213A patent/SE431324B/en not_active IP Right Cessation
- 1977-02-04 DE DE2704690A patent/DE2704690C2/en not_active Expired
- 1977-02-04 CA CA271,086A patent/CA1087212A/en not_active Expired
- 1977-02-04 JP JP1084777A patent/JPS52122352A/en active Granted
- 1977-02-04 PL PL1977195823A patent/PL105534B1/en unknown
- 1977-02-04 YU YU309/77A patent/YU39669B/en unknown
- 1977-02-04 CH CH136077A patent/CH624655A5/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL105534B1 (en) | 1979-10-31 |
| SE431324B (en) | 1984-01-30 |
| SE7701213L (en) | 1977-08-06 |
| ATA59577A (en) | 1978-02-15 |
| CA1087212A (en) | 1980-10-07 |
| JPS52122352A (en) | 1977-10-14 |
| CH624655A5 (en) | 1981-08-14 |
| JPS6149294B2 (en) | 1986-10-29 |
| YU30977A (en) | 1982-06-30 |
| DE2704690A1 (en) | 1977-08-11 |
| YU39669B (en) | 1985-03-20 |
| DE2704690C2 (en) | 1987-01-29 |
| AT345804B (en) | 1978-10-10 |
| NL7701025A (en) | 1977-08-09 |
| HU171269B (en) | 1977-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69204627T2 (en) | Prostaglandins. | |
| US3135788A (en) | Preparation of dl-carnitine hydrochloride from trimethylamine hydrochloride and epihalogenohydrin | |
| SU856376A3 (en) | Method of producing triphenylalkene derivatives | |
| Cope et al. | Reactions of 1-Bromobicyclo [3.3. 1] nonan-9-one | |
| SU562196A3 (en) | The method of obtaining derivatives of decahydroisoquinoline | |
| US2723276A (en) | Coumarin derivatives and process for the manufacture thereof | |
| US3998856A (en) | Preparation of epoxides | |
| US2540116A (en) | Manufacture of condensation products | |
| SU465788A3 (en) | "Method for preparing spiro (dibenzo (a-) -cycloheptadiene or three) derivatives of en-5: 2" (4 "-aminomethyldioxalan 1" 3 ") | |
| Park et al. | OXYMERCURATION OF cis-AND trans-PROPENYLBENZENE | |
| US2898374A (en) | Nucleus alkylated phloracylophenones and procedure for the production of such compounds | |
| US2760975A (en) | Compounds for synthesizing steroids | |
| Overend et al. | 622. Branched-chain sugars. Part IV. The synthesis of D-hamamelose and D-epihamamelose | |
| US3028394A (en) | 9-phenyl octahydroindole compounds and process of making same | |
| US2875227A (en) | Ephedrine salts of 7-carboethoxy-3-acetylthioheptanoic acid | |
| US3322778A (en) | Novel ether derivatives of benzmorphans | |
| US2534823A (en) | 1-keto-2-hydroxymethylene-7-or-1, 2, 3, 4-tetrahydrophenanthrenes | |
| Freudenberg et al. | The Chemistry of Naturally Occurring Monoanhydrohexitols. II. Synthetic Tetramethylstyracitol1 | |
| SU650501A3 (en) | Method of obtaining n,n-dimethyl-3-(4-bromphenyl)-3-(3-pyridyl)-allylamine or salts thereof | |
| SU462331A3 (en) | The method of obtaining 1 -1-azido-1-deoxymio-inositol | |
| US3142683A (en) | 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation | |
| Cheung et al. | Isolation and identification of contaminants found in commercial dihydroquinine | |
| SU431156A1 (en) | METHOD OF OBTAINING BIS | |
| Hey et al. | 43. Internuclear cyclisation. Part XVI. Abnormal reactions of diazonium salts from N-alkyl-2-amino-2′-and-4′-methoxybenzanilides. A new dienone–phenol rearrangement | |
| Vidal | Reaction of ethylene dibromide with triethylamine and the restoring action of some alkanebis (triethylammonium) ions upon sodium-deficient nerve fibers |